» Articles » PMID: 10204638

Cell-associated Infectious HIV-1 Viral Load As a Predictor of Clinical Progression and Survival Among HIV-1 Infected Injection Drug Users and Homosexual Men

Overview
Journal Eur J Epidemiol
Specialty Public Health
Date 1999 Apr 16
PMID 10204638
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Cell-associated infectious HIV-1 viral load was measured using semi-quantitative microculture techniques to determine its predictive capability for progression to AIDS or survival among HIV-1 infected injecting drug users (IDU) and homosexual men (HM). The authors followed 296 IDU and 240 HM from February 1992 through September 1995 for: (i) death, (ii) AIDS, and (iii) AIDS or bacterial infection. At baseline, viral load was quantified using microculture techniques to determine infectious units per million peripheral blood mononuclear cells (IUPM). Data were analyzed using standard statistical methods for survival analysis. Of the 536 total participants, 106 died (20%), and 98 of the 481 AIDS-free participants developed AIDS (20%). The relative hazard of AIDS for a viral load of > or = 100 IUPM, relative to a negative culture (0 IUPM), was 6.73 (95% CI: 2.23-20.3) after adjusting for risk group, initial CD4+ count, and other covariates. The adjusted relative hazard of death for a viral load of > or = 100 IUPM vs. 0 IUPM was 2.57 (95% CI: 0.97 6.80). Viral load predicted time to death within the < 200 cells/ul CD4+ stratum. The predictive value of viral load on HIV-1 progression did not vary by risk group. These data show that cell associated infectious HIV-1 viral load was significantly predictive of progression across risk groups for AIDS and death among those severely immune compromised.

Citing Articles

Rapid dissemination of SIV follows multisite entry after rectal inoculation.

Santos P, Rancez M, Pretet J, Michel-Salzat A, Messent V, Bogdanova A PLoS One. 2011; 6(5):e19493.

PMID: 21573012 PMC: 3090405. DOI: 10.1371/journal.pone.0019493.

References
1.
Paxton W, Coombs R, McElrath M, Keefer M, Hughes J, Sinangil F . Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious.... J Infect Dis. 1997; 175(2):247-54. DOI: 10.1093/infdis/175.2.247. View

2.
Fahey J, Taylor J, Detels R, Hofmann B, Melmed R, Nishanian P . The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990; 322(3):166-72. DOI: 10.1056/NEJM199001183220305. View

3.
Munoz A, Vlahov D, Solomon L, Margolick J, Bareta J, Cohn S . Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr (1988). 1992; 5(7):694-700. View

4.
Jacobson L, Kirby A, Polk S, Phair J, Besley D, Saah A . Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991. Am J Epidemiol. 1993; 138(11):952-64. DOI: 10.1093/oxfordjournals.aje.a116815. View

5.
Enger C, Graham N, Peng Y, Chmiel J, Kingsley L, Detels R . Survival from early, intermediate, and late stages of HIV infection. JAMA. 1996; 275(17):1329-34. View